Cited by 25Chronic Kidney Disease and DiabetesNatural Antidiabetic Agents StudiesDiet, Metabolism, and Disease

Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats

Open access
Kubota, Masatoshi, Watanabe, Reiko, Yamaguchi, Miki, Hosojima, Michihiro, Saito, Akihiko, Fujii, Mikio, Fujimura, Shinobu, Kadowaki, Motoni·2016·British Journal Of Nutrition

Abstract

We previously reported that rice endosperm protein (REP) has renoprotective effects in Goto-Kakizaki rats, a non-obese diabetic model. However, whether these effects occur in obese diabetes remains unclear. This study aimed to clarify the effects of REP on obese diabetes, especially on fatty liver and diabetic nephropathy, using the obese diabetic model Zucker diabetic fatty (ZDF) rats. In total, 7-week-old male ZDF rats were fed diets containing 20 % REP or casein (C) for 8 weeks. Changes in fasting blood glucose levels and urinary markers were monitored during the experimental period. Hepatic lipids and metabolites were measured and renal glomeruli were observed morphologically. HbA1c levels were significantly lower in rats fed REP, compared with C (P<0·05). Compared with C in the liver, REP prevented lipid accumulation (total lipid, TAG and total cholesterol, P<0·01). Liver metabolome analysis indicated that levels of metabolites associated with glycolysis, the pentose phosphate pathway and carnitine metabolism were significantly greater in the REP group than in the C group (P<0·05), suggesting activation of both glucose catabolism and fatty acid oxidation. The metabolite increases promoted by REP may contribute to suppression of liver lipid accumulation. Urinary excretion of albumin and N-acetyl-β-d-glucosaminidase was significantly reduced in rats fed REP for 8 weeks (P<0·01). In addition, there was a distinct suppression of mesangial matrix expansion and glomerular hypertrophy in response to REP (P<0·01). Thus, REP had preventive effects on obese diabetes, fatty liver and diabetic nephropathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114516003512

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kubota, M., Watanabe, R., Yamaguchi, M., Hosojima, M., Saito, A., Fujii, M., Fujimura, S., & Kadowaki, M.
Affiliations
  • Niigata University (JP)
  • University of Niigata Prefecture (JP)
  • Kameda Seika Co., Ltd. (Japan) (JP)
Corresponding author
Kubota, Masatoshi
Venue
British Journal Of Nutrition
Published
2016-10-11
Volume
116
Issue
8
Pages
1326-1335
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
OpenAlex
W2530487514
Cited by
25
References
46
Citations by year
2024: 5 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2017: 3 · 2016: 1
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • British Journal Of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (16K00855, 26461216, 26292066)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
hepatic steatosis, diabetic nephropathy, Zucker diabetic fatty rats, hepatic lipid accumulation, liver metabolome, glycolysis, pentose phosphate pathway, carnitine metabolism, fatty acid oxidation, albuminuria, N-acetyl-beta-D-glucosaminidase, mesangial expansion, glomerular hypertrophy, HbA1c, dietary protein
MeSH terms
Hypoadrenocorticism, Familial, Animals, Carbohydrate Metabolism, Inborn Errors, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Energy Metabolism, Glycerol Kinase, Kidney Glomerulus, Liver, Male, Obesity, Organ Size, Rats, Zucker, Oryza, Plant Proteins, Dietary, Diet, Vegetarian, Biomarkers, Weight Gain, Disease Progression, Lipid Metabolism, Renal Insufficiency, Chronic, Hyperphosphatemia, Endosperm, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review